Lexicon Pharma (LXRX) Announces COO Departuree
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Join SI Premium – FREE
On September 13, 2024, Lexicon Pharma (NASDAQ: LXRX) and Jeffrey L. Wade determined that his employment as our president and chief operating officer (in which capacity, Mr. Wade has functioned as our principal financial officer) would terminate as of September 30, 2024.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump approval at 33%, lowest of his presidency - Reuters/Ipsos
- Tutor Perini wins $60M Coast Guard contract in Florida
- Synchrony partners with OpenAI to integrate AI into shopping
Create E-mail Alert Related Categories
8K, Corporate News, Management ChangesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
